The Current Status of Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Leukemia - United Kingdom
doi 10.1038/sj.leu.2404333
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Hematopoietic Stem Cell Transplantation for Multiple Myeloma Beyond 2010

Blood
BiochemistryImmunologyCell BiologyHematology
2010English

CD34-selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed, High-Risk Multiple Myeloma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma

Seminars in Hematology
Hematology
2009English

Allogeneic Hematopoietic Stem Cell Transplantation

Archives of Internal Medicine
2002English

Health-Related Quality of Life in Patients Receiving Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2006English

The Impact of Donor Gender on Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Reduced Relapse Risk in Female to Male Transplants

Bone Marrow Transplantation
TransplantationHematology
2005English

Allogeneic Hematopoietic Cell Transplantation for Consolidation of VGPR or CR for Newly Diagnosed Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2013English

Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in Adults With Acute Myeloid Leukemia

Cancer Control
MedicineOncologyHematology
2011English

Complete Remission of Psoriasis After Autologous Hematopoietic Stem-Cell Transplantation for Multiple Myeloma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy